CAMP4 Therapeutics (CAMP) Financials: Revenue & Earnings

CAMP price $3.62 -0.03 -0.82%

Ticker
CAMP
Price
$3.62
Change
-0.03 -0.82%
Market cap ?
$227.17M
P/E ?
-1.44
Dividend yield ?
0.00%
Beta ?
0.21
Sector
Healthcare
Industry
Biotechnology

Financials

202320242025
3500006520003498000

CAMP4 Therapeutics Corporation, a biotechnology firm, was established in 2015 by Richard A. Young and Leonard Zon. Based in Cambridge, Massachusetts, its core focus is the identification and development of new therapeutic solutions for patients.

Fair value

CAMP fair value Not meaningful. Price $3.62.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Not meaningful

Compare CAMP

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-08-13-0.58-0.211.78M1.62M
2026-05-07-0.32-0.211.29M1.12M
2026-03-05-0.87-0.31300.00K475.20K
2025-11-06-0.55-0.47795.00K433.33K
2025-08-14-0.62-0.671.50M571.78K
2025-05-13-0.62-0.70858.00K214.50K
2025-03-27-0.77-0.91652.00K676.00K
2025-02-20-24.19-0.82—250.00K
2024-07-08-52.56-0.92—51.27M
2024-06-06-1.03-2.04—51.27M
2024-01-09-3.91-2.3053.62M56.20M
2023-10-05-0.010.0361.71M70.35M
2023-07-10-0.230.9270.89M75.66M
2023-04-271.380.0378.51M78.65M
2022-12-20-0.060.0578.89M75.29M
2022-09-22-0.46-0.6572.83M69.27M
2022-06-23-2.30-0.7364.73M69.43M
2022-04-28-0.23-1.2668.38M68.44M
2021-12-21-1.84-0.2368.78M68.60M
2021-09-231.841.3879.01M177.77M
2021-06-241.841.6179.67M80.25M
2021-04-223.221.1581.95M83.68M
2020-12-170.690.6988.01M754.17M
2020-09-24-0.69-0.4683.54M76.84M
2020-06-250.46-0.6980.22M200.54M
2020-05-050.690.6987.20M80.22M
2019-12-193.453.4596.60M96.60M
2019-09-263.222.5393.24M79.92M
2019-06-272.762.0789.07M66.80M
2019-04-300.335.7584.38M78.35M
2018-12-205.750.2388.50M81.42M
2018-09-277.130.2896.04M86.75M
2018-06-270.290.2894.89M91.62M
2018-04-266.900.2994.39M91.25M
2017-12-210.330.2993.67M87.63M
2017-09-286.210.2689.77M86.45M
2017-06-276.670.2788.08M82.01M
2017-04-186.440.2786.13M83.05M
2016-12-214.830.3183.35M103.20M
2016-09-296.210.2790.48M90.48M

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-08-31Gold KellyBuy10.00K$3.9639.60K
2026-08-27Schwab Andrew J.Sell400.00K$4.041.62M
2026-08-24Schwab Andrew J.Sell10$4.5045
2026-08-21Schwab Andrew J.Sell32.02K$4.50144.08K
2026-08-20Schwab Andrew J.Sell114.70K$4.54520.74K
2026-08-19Schwab Andrew J.Sell45.15K$4.76214.90K
2026-08-19Tardiff DanielSell1.74K$4.768.27K
2026-08-035AM Partners VI, LLCBuy3.18M$0.00318
2026-08-03Schwab Andrew J.Buy3.18M$0.00318
2026-08-03Young Richard ABuy16.38K$1.6527.02K
2026-08-03Maricich YuriBuy6.55K$1.6510.81K
2026-08-03Gold KellyBuy6.55K$1.6510.81K
2026-08-03Mandel-Brehm JoshBuy6.55K$1.6510.81K
2026-06-10WILLIAMS DOUGLAS EBuy28.00K$4.34121.52K
2026-06-10Young Richard ABuy28.00K$4.34121.52K
2026-06-10Schwab Andrew J.Buy28.00K$4.34121.52K
2026-06-10Holtzman Steven HBuy28.00K$4.34121.52K
2026-06-10Stewart MurrayBuy28.00K$4.34121.52K
2026-06-10Nashat AmirBuy28.00K$4.34121.52K
2026-04-01Tardiff DanielBuy170.00K$4.46758.20K
2026-04-01Maricich YuriBuy215.00K$4.46958.90K
2026-04-01Gold KellyBuy215.00K$4.46958.90K
2026-04-01Mandel-Brehm JoshBuy580.00K$4.462.59M
2026-04-01MacLean Michael FBuy56.00K$4.46249.76K
2026-04-01MacLean Michael FOther0——
2025-12-11Tardiff DanielBuy145.50K$6.01874.46K
2025-12-11Maricich YuriBuy190.00K$6.011.14M
2025-12-11Gold KellyBuy190.00K$6.011.14M
2025-12-11Mandel-Brehm JoshBuy425.00K$6.012.55M
2025-10-01Tardiff DanielOther5.00K$3.5317.65K
2025-10-01Tardiff DanielOther25.00K$3.8696.50K
2025-10-01Tardiff DanielOther22.29K$9.08202.38K
2025-09-11Schwab Andrew J.Buy2.94M$1.534.50M
2025-09-115AM Partners VI, LLCBuy2.94M$1.534.50M
2025-09-11Polaris Management Co. VII, L.L.C.Buy1.22M$1.531.87M
2025-09-11Polaris Management Co. VII, L.L.C.Buy85.47K$1.53130.77K
2025-09-11Nashat AmirBuy1.22M$1.531.87M
2025-09-11Nashat AmirBuy85.47K$1.53130.77K
2025-09-11Maricich YuriBuy6.06K$1.6510.00K
2025-09-11Gold KellyBuy6.06K$1.6510.00K
2025-09-11Mandel-Brehm JoshBuy6.06K$1.6510.00K
2025-09-11Young Richard ABuy15.15K$1.6525.00K
2025-06-25Boylan James PBuy9.00K$1.5614.04K
2025-06-25Young Richard ABuy9.00K$1.5614.04K
2025-06-25Higgins Michael JBuy9.00K$1.5614.04K
2025-06-25Schwab Andrew J.Buy9.00K$1.5614.04K
2025-06-25Holtzman Steven HBuy9.00K$1.5614.04K
2025-06-25Nashat AmirBuy9.00K$1.5614.04K
2025-06-25Thadhani Ravi I.Buy9.00K$1.5614.04K
2025-06-25Ragan PaulaBuy9.00K$1.5614.04K
2025-04-01Bumcrot DavidBuy45.00K$3.86173.70K
2025-04-01Maricich YuriBuy80.00K$3.86308.80K
2025-04-01Gold KellyBuy80.00K$3.86308.80K
2025-04-01Mandel-Brehm JoshBuy160.00K$3.86617.60K
2025-03-17WILLIAMS DOUGLAS EOther0——
2025-03-17WILLIAMS DOUGLAS EBuy17.79K$5.3795.52K
2025-03-17Stewart MurrayBuy17.79K$5.3795.52K
2025-03-17WILLIAMS DOUGLAS EOther0——
2025-03-17Stewart MurrayOther0——
2024-10-15Polaris Management Co. VII, L.L.C.Buy353.72K——
2024-10-15Polaris Management Co. VII, L.L.C.Buy1.25M——
2024-10-15Polaris Management Co. VII, L.L.C.Buy909.09K$11.0010.00M
2024-10-15Polaris Management Co. VII, L.L.C.Buy24.75K——
2024-10-15Polaris Management Co. VII, L.L.C.Buy87.45K——
2024-10-15Polaris Management Co. VII, L.L.C.Sell980.83K——
2024-10-15Polaris Management Co. VII, L.L.C.Sell277.54K——
2024-10-15Polaris Partners GP X, L.L.C.Other0——
2024-10-15Northpond Ventures II GP, LLCBuy1.00M——
2024-10-15Northpond Ventures II GP, LLCBuy763.64K$11.008.40M
2024-10-15Northpond Ventures II GP, LLCBuy471.42K——
2024-10-15Northpond Ventures II GP, LLCSell11.25M——
2024-10-15Northpond Ventures II GP, LLCSell5.29M——
2024-10-15AH Equity Partners Bio I, L.L.C.Buy181.82K$11.002.00M
2024-10-15AH Equity Partners Bio I, L.L.C.Buy1.40M——
2024-10-15AH Equity Partners Bio I, L.L.C.Buy545.45K$11.006.00M
2024-10-15AH Equity Partners Bio I, L.L.C.Sell679.16K——
2024-10-15AH Equity Partners Bio I, L.L.C.Sell15.00M——
2024-10-15Enavate Sciences GP, LLCBuy1.36M$11.0015.00M
2024-10-15Enavate Sciences GP, LLCBuy2.42M——
2024-10-15Enavate Sciences GP, LLCSell27.17M——
2024-10-155AM Partners VI, LLCBuy909.09K$11.0010.00M
2024-10-155AM Partners VI, LLCBuy1.72M——
2024-10-155AM Partners VI, LLCBuy302.77K——
2024-10-155AM Partners VI, LLCSell15.00M——
2024-10-155AM Partners VI, LLCSell3.40M——
2024-10-15Nashat AmirBuy353.72K——
2024-10-15Nashat AmirBuy1.25M——
2024-10-15Nashat AmirBuy909.09K$11.0010.00M
2024-10-15Nashat AmirBuy24.75K——
2024-10-15Nashat AmirBuy87.45K——
2024-10-15Nashat AmirSell980.83K——
2024-10-15Nashat AmirSell277.54K——
2024-10-15Schwab Andrew J.Buy909.09K$11.0010.00M
2024-10-15Schwab Andrew J.Buy378.46K——
2024-10-15Schwab Andrew J.Buy1.34M——
2024-10-15Schwab Andrew J.Buy302.77K——
2024-10-15Schwab Andrew J.Sell15.00M——
2024-10-15Schwab Andrew J.Sell3.40M——
2024-10-15Holtzman Steven HBuy8.92K——
2024-10-15Holtzman Steven HSell100.01K——

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 62, holders +15 vs prior quarter. Ownership 72.12%.

HolderSharesChangeChange %Value
JUPITER TOPCO LLC6.31M6.31MNew27.58M
5AM VENTURE MANAGEMENT, LLC5.87M00.00%25.65M
FMR LLC4.90M-29.09K-0.59%21.43M
VIVO CAPITAL, LLC4.25M00.00%18.56M
BALYASNY ASSET MANAGEMENT L.P.2.58M-56.71K-2.15%11.26M
A16Z CAPITAL MANAGEMENT, L.L.C.2.13M00.00%9.29M
ADAGE CAPITAL PARTNERS GP, L.L.C.1.96M00.00%8.57M
TRAILS EDGE CAPITAL PARTNERS, LP1.93M-6.63K-0.34%8.45M
BLACKROCK, INC.1.64M1.19M+260.26%7.18M
VANGUARD CAPITAL MANAGEMENT LLC1.53M-1.28K-0.08%6.70M
ENAVATE SCIENCES GP, LLC1.43M-765.38K-34.93%6.23M
STONEPINE CAPITAL MANAGEMENT, LLC1.39M00.00%6.07M
HARBOURVEST PARTNERS LLC1.27M00.00%5.56M
GEODE CAPITAL MANAGEMENT, LLC795.65K412.83K+107.84%3.48M
SUMMITTX CAPITAL, L.P.725.16K385.64K+113.58%3.17M
SILVERARC CAPITAL MANAGEMENT, LLC653.59K00.00%2.86M
STATE STREET CORP362.30K215.40K+146.63%1.58M
NORTHERN TRUST CORP248.67K178.01K+251.90%1.09M
GOLDMAN SACHS GROUP INC241.39K163.05K+208.12%1.05M
VANGUARD FIDUCIARY TRUST CO226.07K31.06K+15.93%987.94K
VANGUARD PORTFOLIO MANAGEMENT LLC220.72K220.72KNew964.53K
BIRCHVIEW CAPITAL, LP120.00K120.00KNew524.40K
TWO SIGMA INVESTMENTS, LP104.61K-4.26K-3.92%457.15K
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P.96.66K96.66KNew422.40K
CHARLES SCHWAB INVESTMENT MANAGEMENT INC96.66K76.66K+383.30%422.40K

Earnings and financials

CAMP4 Therapeutics Corporation (CAMP) trades at $3.62, with a market cap of $227.17M and a trailing P/E of -1.44. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Financials

202320242025
3500006520003498000

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

CAMP4 Therapeutics (CAMP) Financials: Revenue & Earnings

CAMP$3.62-0.03 -0.82%

$227.17M

Market Cap

-1.44

P/E

—

Forward P/E

—

Score

Price History